Skip to main content
Clinical Trials/NCT06446492
NCT06446492
Completed
Not Applicable

Impact of Video-Enhanced Consent on Informed Decision-Making for Parents of Extremely Preterm Infants Eligible for the ViDES Study: A Randomized Controlled Trial

The University of Texas Health Science Center, Houston1 site in 1 country83 target enrollmentJuly 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Understanding of Consent in Clinical Research
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
83
Locations
1
Primary Endpoint
Participants' understanding of the ViDES study as assessed by a questionnaire
Status
Completed
Last Updated
10 months ago

Overview

Brief Summary

This pilot randomized controlled trial evaluates the impact of video-enhanced consent compared to the usual approach. The investigators aim to assess if video-enhanced consent empowers decision-making and improves understanding in parents considering participation in the ViDES study, which investigates the effectiveness of Vitamin D supplementation in extremely preterm infants (the ViDES study is separately registered as NCT05459298).

Registry
clinicaltrials.gov
Start Date
July 1, 2024
End Date
June 15, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Maria del Mar Romero López

Assistant Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Parents/legal guardians of extremely preterm infants (\<28 weeks gestational age or \<1000 g birth weight) admitted to the Neonatal Intensive Care Unit at Children's Memorial Hermann hospital that qualify for the ViDES study (ViDES study is separately registered as NCT05459298)

Exclusion Criteria

  • Parents/legal guardians deaf or blind
  • Parents/legal guardians unable to consent for the VIDES study

Outcomes

Primary Outcomes

Participants' understanding of the ViDES study as assessed by a questionnaire

Time Frame: Within 48 hours of the intervention

The questionnaire assesses recall of possible benefits and risks of participation.

Participants' satisfaction with consent approach as assessed by a questionnaire

Time Frame: Within 48 hours of the intervention

The questionnaire assesses satisfaction with ability to ask questions and decision time.

ViDES trial consent rate

Time Frame: Within 1 week of the intervention

Participant's opinions related to participation in research as assessed by a questionnaire

Time Frame: Within 48 hours of the intervention

The questionnaire assesses participant's opinions related to participation in research and research being part of the care of infants.

Study Sites (1)

Loading locations...

Similar Trials